Daily low-dose aspirin has long been considered a “wonder drug” for its cardioprotective effects, particularly in patients with pre-existing cardiovascular and cerebrovascular disease; however, despite decades of research, the use of aspirin to prevent a first event is less certain. In 2014, the Food and Drug Administration (FDA) responded to a citizen petition requesting the labeled indications for low dose aspirin be updated to include primary prevention. The FDA concluded that the evidence “fail[ed] to establish that aspirin reduces the risk of primary myocardial infarction (MI) in patients with a coronary heart disease (CHD) risk of 10% or more for over 10 years.” The Asprin to Reduce Risk of Initial Vascular Events (ARRIVE) study is intended to address this gap in our knowledge.
Guest Authors: Amy St. Amand, PharmD, BCPS and Christine Borowy, PharmD, BCPS
Music by Good Talk
Beyond Statins: Approaches to Lipid Lowering in 2023
Fixed Dose or Treat-to-Target: Does LODESTAR Guide Us on Statin Management?
Making the GRADE: Durability of Glycemic Response in Type 2 Diabetes
Pop Health and Am Care Pharmacy Practice: Achieving Higher Quality, Lower Cost
Top Ten Things Every Clinician Should Know About the KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease
Is In-Personal Care Better than Care Delivered at a Distance?
How Many Patients Can a Pharmacist Reasonably Manage? Estimating An Appropriate Panel Size
Is There a CLEAR Role for Bempedoic Acid in Cardiovascular Risk Reduction?
Is MBSR* as Good as Meds for Anxiety Disorders?
GLP-1 Receptor Agonists and SGLT2 Inhibitors: Don’t Sugarcoat the Costs!
Is Combination Therapy Superior to Monotherapy for Painful Diabetic Peripheral Neuropathy?
How VITAL is Vitamin D in Preventing Statin Associated Muscle Symptoms (SAMS)?
Under Pressure: Measuring and Managing Hypertension
Top Ten Things Every Clinician Should Know About Payment for Pharmacists’ Patient Care Services
Complex Patient Case 2 - Managing Adverse Effects
Preventing Autoimmune Disease: Can Supplements Get the Job Done?
Top Ten Things Every Clinician Should Know About Treating Obesity
Managing RAAS-Inhibitor-Associated Hyperkalemia in Patients with CKD – A Balancing Act
Complex Patient Case - Women’s Health + Contraception
Top Ten Podcasts Every Ambulatory Care Clinician Should Know About
Create your
podcast in
minutes
It is Free
Good Mood Revolution
The Relaxback UK Show
On Call With Dr. Anselm Anyoha
Precision Medicine Forum Podcast
The Doctor’s Farmacy with Mark Hyman, M.D.
The Peter Attia Drive